PMID- 21804938 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20111110 LR - 20211020 IS - 2090-1259 (Electronic) IS - 2090-1240 (Print) IS - 2090-1240 (Linking) VI - 2011 DP - 2011 TI - Graves' Disease as a Manifestation of Immune Reconstitution in HIV-Infected Individuals after Initiation of Highly Active Antiretroviral Therapy. PG - 743597 LID - 10.1155/2011/743597 [doi] LID - 743597 AB - Graves' disease after the initiation of highly active antiretroviral therapy (HAART) in certain HIV-1-infected individuals has been described as an immune reconstitution inflammatory syndrome (IRIS). This phenomenon should be suspected in individuals who present with clinical deterioration and a presentation suggestive of hyperthyroidism despite good virological and immunological response to HAART. Signs and symptoms of hyperthyroidism may be discrete or overt and typically develop 8-33 months after initiating therapy. One to two percent of HIV-infected patients can present with overt thyroid disease. Relatively few cases of Graves' IRIS have been reported in the literature to date. We describe four cases of Graves' IRIS in HIV-infected patients who were started on HAART therapy. FAU - Rasul, Samad AU - Rasul S AD - Division of Infectious Diseases, Department of Internal Medicine, Howard University Hospital, Washington DC, USA. FAU - Delapenha, Robert AU - Delapenha R FAU - Farhat, Faria AU - Farhat F FAU - Gajjala, Jhansi AU - Gajjala J FAU - Zahra, Syeda Mehreen AU - Zahra SM LA - eng PT - Case Reports DEP - 20110725 PL - United States TA - AIDS Res Treat JT - AIDS research and treatment JID - 101553816 PMC - PMC3144671 EDAT- 2011/08/02 06:00 MHDA- 2011/08/02 06:01 PMCR- 2011/07/25 CRDT- 2011/08/02 06:00 PHST- 2011/01/31 00:00 [received] PHST- 2011/05/10 00:00 [accepted] PHST- 2011/08/02 06:00 [entrez] PHST- 2011/08/02 06:00 [pubmed] PHST- 2011/08/02 06:01 [medline] PHST- 2011/07/25 00:00 [pmc-release] AID - 10.1155/2011/743597 [doi] PST - ppublish SO - AIDS Res Treat. 2011;2011:743597. doi: 10.1155/2011/743597. Epub 2011 Jul 25.